Dr. Glen Noble

Glen Noble

Dr. Glen Noble

Dr. Glen Noble brings to Gryphon over 20 years of experience in medicinal chemistry and 17 years in chemical database management. Dr. Noble holds a PhD in medicinal chemistry, and his research interests include developing radiopharmaceuticals useful for mapping biological receptors. Dr. Noble was first introduced to chemical database management at GlaxoSmithKline and Eli Lilly and Company. At Gryphon, Dr. Noble supports NIAID’s ChemDB database, a chemical structure-based database containing quantitative biological information on compounds tested against HIV, tuberculosis and other related opportunistic pathogens.

You’d expect an incredibly methodical data base manager to like crossword and jigsaw puzzles. But his love of Sci-fi and fantasy books breaks the mold.